MicroRNA sequencing

MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer[1] has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.[2] Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).[3]

  1. ^ Farazi, Thalia A; Spitzer, Jessica I; Morozov, Pavel; Tuschl, Thomas (2011). "miRNAs in human cancer". The Journal of Pathology. 223 (2): 102–115. doi:10.1002/path.2806. ISSN 0022-3417. PMC 3069496. PMID 21125669.
  2. ^ Sandhu, S.; Garzon, R. (2011). "Potential Applications of MicroRNAs in Cancer Diagnosis, Prognosis, and Treatment". Semin Oncol. 38 (6): 781–787. doi:10.1053/j.seminoncol.2011.08.007. PMID 22082764.
  3. ^ Cite error: The named reference Baker2010 was invoked but never defined (see the help page).

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search